Metabolic support of tumour-infiltrating regulatory T cells by lactic acid MLJ Watson, PDA Vignali, SJ Mullett, AE Overacre-Delgoffe, RM Peralta, ... Nature 591 (7851), 645-651, 2021 | 808 | 2021 |
Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axis GM Delgoffe, SR Woo, ME Turnis, DM Gravano, C Guy, AE Overacre, ... Nature 501 (7466), 252-256, 2013 | 643 | 2013 |
Interferon-γ drives Treg fragility to promote anti-tumor immunity AE Overacre-Delgoffe, M Chikina, RE Dadey, H Yano, EA Brunazzi, ... Cell 169 (6), 1130-1141. e11, 2017 | 595 | 2017 |
Distinct TCR signaling pathways drive proliferation and cytokine production in T cells CS Guy, KM Vignali, J Temirov, ML Bettini, AE Overacre, M Smeltzer, ... Nature immunology 14 (3), 262-270, 2013 | 278 | 2013 |
Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer AE Overacre-Delgoffe, HJ Bumgarner, AR Cillo, AHP Burr, JT Tometich, ... Immunity 54 (12), 2812-2824. e4, 2021 | 206 | 2021 |
Considerations for treatment duration in responders to immune checkpoint inhibitors TU Marron, AE Ryan, SM Reddy, S Kaczanowska, RH Younis, D Thakkar, ... Journal for immunotherapy of cancer 9 (3), 2021 | 98 | 2021 |
Treg fragility: a prerequisite for effective antitumor immunity? AE Overacre-Delgoffe, DAA Vignali Cancer immunology research 6 (8), 882-887, 2018 | 95 | 2018 |
Treg stability: to be or not to be AE Overacre, DAA Vignali Current opinion in immunology 39, 39-43, 2016 | 72 | 2016 |
Environmental enteric dysfunction induces regulatory T cells that inhibit local CD4+ T cell responses and impair oral vaccine efficacy A Bhattacharjee, AHP Burr, AE Overacre-Delgoffe, JT Tometich, D Yang, ... Immunity 54 (8), 1745-1757. e7, 2021 | 46 | 2021 |
Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer CA Chuckran, AR Cillo, J Moskovitz, A Overacre-Delgoffe, ... Science translational medicine 13 (623), eabf8495, 2021 | 29 | 2021 |
Effects of antidepressant treatment on mice lacking brain‐derived neurotrophic factor expression through promoter IV K Sakata, JR Mastin, SM Duke, MG Vail, AE Overacre, BE Dong, S Jha European Journal of Neuroscience 37 (11), 1863-1874, 2013 | 28 | 2013 |
Regulation of tissue-resident memory T cells by the Microbiota AE Overacre-Delgoffe, TW Hand Mucosal immunology 15 (3), 408-417, 2022 | 25 | 2022 |
Promoter IV‐BDNF deficiency disturbs cholinergic gene expression of CHRNA 5, CHRM 2, and CHRM 5: effects of drug and environmental treatments K Sakata, AE Overacre Journal of neurochemistry 143 (1), 49-64, 2017 | 20 | 2017 |
Effects of salt, polyethylene glycol, and locked nucleic acids on the thermodynamic stabilities of consecutive terminal adenosine mismatches in RNA duplexes X Gu, MT Nguyen, A Overacre, S Seaton, SJ Schroeder The Journal of Physical Chemistry B 117 (13), 3531-3540, 2013 | 18 | 2013 |
Excess Dietary Sugar Alters Colonocyte Metabolism and Impairs the Proliferative Response to Damage AHP Burr, J Ji, K Ozler, HL Mentrup, O Eskiocak, B Yueh, R Cumberland, ... Cellular and molecular gastroenterology and hepatology 16 (2), 287-316, 2023 | 11 | 2023 |
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016 A Lundqvist, V van Hoef, X Zhang, E Wennerberg, J Lorent, K Witt, ... Journal for immunotherapy of cancer 4, 1-106, 2016 | 10 | 2016 |
Treg fragility: a prerequisite for effective antitumor immunity? Cancer Immunol. Res. 2018; 6: 882–887. doi: 10.1158/2326-6066 AE Overacre-Delgoffe, DAA Vignali CIR-18-0066.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 10 | |
Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies KG Anderson, DA Braun, A Buqué, SB Gitto, JL Guerriero, B Horton, ... Journal for immunotherapy of cancer 11 (6), 2023 | 6 | 2023 |
The complex immunological role of Helicobacter in modulating cancer TW Hand, AE Overacre-Delgoffe Trends in Immunology 43 (10), 826-832, 2022 | 3 | 2022 |
Combination immunotherapy: Where do we go from here? AE Overacre, S Kurtulus, M Sznol, DM Pardoll, A Anderson, DAA Vignali Journal for immunotherapy of cancer 3, 1-3, 2015 | 3 | 2015 |